← SearchRapid Field Appropriate Diagnostics of Select Emerging and Biodefense Pathogens$423,743R33FY2015AINIHLucigen Corporation, Middleton WIInvestigatorsYogesh ChandercontactLinked publications, trials & patentsPaper 27638947View original record on NIH RePORTER →